Skip to Main Content

Paper Details

Development and Validation of a Treatment Benefit Index to Identify Hospitalized Patients With COVID-19 Who May Benefit From Convalescent Plasma.
JAMA Netw Open
31
2022
-19, CCP, COVID, COVID-19, Patients, TBI, cardiovascular and pulmonary diseases, diabetes, participants, patient, patients, women
Author NameAffiliation
Mengling LiuNew York University Grossman School of Medicine
Mengling LiuNew York University Grossman School of Medicine
Nicole VerdunCenter for Biologics Evaluation and Research
Geert MeyfroidtUniversity Hospitals Leuven
Mila B OrtigozaNew York University Grossman School of Medicine
Liise-Anne PirofskiAlbert Einstein College of Medicine and Montefiore Medical Center
Elliott M AntmanBrigham and Women's Hospital, Harvard Medical School
  • 1 - 7

Datasets

Release 1.2